Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T15:33:49.608Z.
Calculation as of: 2026-10-06T15:33:49.608Z.
Quote observation: 2026-10-06T15:30:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fb4a8502ebbb15e11e68a15a33f7d53c7b5c9812bb79594c7d74d11368e8432a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Milestone Pharmaceuticals Inc.
Market Cap
$97.81M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$96.58M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$94.07M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$103.09M
EV/EBIT Ratio
N/A
TTM Avg
28.81x
3Y Avg
28.81x
5Y Avg
28.81x
Market Cap
$102.64M
EV/EBIT Ratio
57.50x
TTM Avg
89.36x
3Y Avg
94.92x
5Y Avg
1303.85x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $97.81M | N/A | N/A | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $98.39M | N/A | N/A | N/A | N/A |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $96.58M | N/A | N/A | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $99.52M | 81.21x | 96.06x | 96.06x | 12.74x |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $94.07M | N/A | N/A | N/A | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $93.27M | N/A | N/A | N/A | N/A |
| Anixa Biosciences, Inc. (ANIX)vs › | $103.09M | N/A | 28.81x | 28.81x | 28.81x |
| The Joint Corp. (JYNT)vs › | $102.64M | 57.50x | 89.36x | 94.92x | 1303.85x |
| Conexeu Sciences Inc. (CNXU)vs › | $93.47M | N/A | N/A | N/A | N/A |
| Equillium, Inc. (EQ)vs › | $92.31M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
